GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Aveo Healthcare Ltd (ASX:AEH) » Definitions » 3-Year RORE %

Aveo Healthcare (ASX:AEH) 3-Year RORE % : 0.00% (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Aveo Healthcare 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Aveo Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2013 was 0.00%.

The industry rank for Aveo Healthcare's 3-Year RORE % or its related term are showing as below:

ASX:AEH's 3-Year RORE % is not ranked *
in the Real Estate industry.
Industry Median: -0.235
* Ranked among companies with meaningful 3-Year RORE % only.

Aveo Healthcare 3-Year RORE % Historical Data

The historical data trend for Aveo Healthcare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveo Healthcare 3-Year RORE % Chart

Aveo Healthcare Annual Data
Trend Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aveo Healthcare Semi-Annual Data
Jun04 Dec04 Jun05 Dec05 Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aveo Healthcare's 3-Year RORE %

For the Real Estate Services subindustry, Aveo Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aveo Healthcare's 3-Year RORE % Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Aveo Healthcare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Aveo Healthcare's 3-Year RORE % falls into.



Aveo Healthcare 3-Year RORE % Calculation

Aveo Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2013 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.017-0.437 )/( -0.326-0.11 )
=-0.454/-0.436
=104.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2013 and 3-year before.


Aveo Healthcare  (ASX:AEH) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Aveo Healthcare 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Aveo Healthcare's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveo Healthcare (ASX:AEH) Business Description

Traded in Other Exchanges
N/A
Address
Aveo Healthcare Ltd provides retirement communities in South-East Queensland. The Company's healthcare's portfolio comprises five retirement villages, located in Albany Creet, Clayfield, Cleveland, Durack and Taringa.

Aveo Healthcare (ASX:AEH) Headlines

From GuruFocus

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 06-15-2022

AM Best Affirms Credit Ratings of Aegon N.V.'s U.S. Subsidiaries

By Business Wire Business Wire 11-03-2022

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 06-05-2022

Aegon Bank publishes its 2020 annual report

By Business Wire Business Wire 04-30-2021

Aegon Bank has set up an additional Covered Bond Program

By Business Wire Business Wire 05-10-2021

Aegon appoints Will Fuller as President and CEO of Transamerica

By Business Wire Business Wire 03-11-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 07-15-2022

Aegon completes share buyback program

By Business Wire Business Wire 08-23-2021